MedPath

norethindrone acetate and ethinyl estradiol and ferrous fumarate

These highlights do not include all the information needed to use NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS AND FERROUS FUMARATE TABLETS safely and effectively. See full prescribing information for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS AND FERROUSFUMARATE TABLETS. Norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets, for oral useInitial U.S. Approval: 1968

Approved
Approval ID

570670c0-b88f-4e78-a978-498aff52b410

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 26, 2017

Manufacturers
FDA

Glenmark Pharmaceuticals Inc., USA

DUNS: 130597813

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

norethindrone acetate and ethinyl estradiol and ferrous fumarate

PRODUCT DETAILS

NDC Product Code68462-376
Application NumberANDA210369
Marketing CategoryC73584
Route of AdministrationN/A
Effective DateDecember 26, 2017
Generic Namenorethindrone acetate and ethinyl estradiol and ferrous fumarate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

norethindrone acetate and ethinyl estradiol and ferrous fumarate - FDA Drug Approval Details